MHRA highlights “remarkable” progress and launches real-world data consultation on International Clinical Trials Day

Tuesday, 20 May 2025 08:01

Major progress has been made in delivering a more efficient and adaptable regulatory framework for clinical trials, the Chief Executive of the Medicines and Healthcare products Regulatory Agency (MHRA) has reflected on International Clinical Trials Day. New regulations – which represent the most significant update to the UK clinical trials landscape in 20 years – are designed to put participants firmly at the centre of how trials are run, while supporting faster, more...Request free trial